Xenon Pharmaceuticals Inc Earnings logo

XENE

Xenon Pharmaceuticals Inc Earnings

$35.09

Earnings Summary

Revenue
$0Mn
Net Profits
$-65.69Mn
Net Profit Margins
-Inf%
Highlights
Revenue:

Xenon Pharmaceuticals Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2024. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Xenon Pharmaceuticals Inc’s net profit fell -46.81% since last year same period to $-65.69Mn in the Q4 2024. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated -4.61% fall in its net profits since last 3-months.

Net Profit Margins:

Xenon Pharmaceuticals Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2024. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Xenon Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter
-0.84
EPS Estimate Current Year
-0.84
Highlights
EPS Estimate Current Quarter:

Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.84 - a -3.6% fall from last quarter’s estimates.

EPS Estimate Current Year:

Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.84.

Key Ratios

Key ratios of the Xenon Pharmaceuticals Inc post its Q4 2024 earnings
Earning Per Share (EPS)
-0.84
Highlights
Earning Per Share (EPS):

Xenon Pharmaceuticals Inc’s earning per share (EPS) fell -31.25% since last year same period to -0.84 in the Q4 2024. This indicates that the Xenon Pharmaceuticals Inc has generated -31.25% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-08-08
-0.7
-0.75
-7.14%
2025-02-27
-0.84
-0.84
-0.1%
2024-05-09
-0.66
-0.62
6.06%
2024-11-12
-0.81
-0.81
0%